Results: 1711

For: Treatment

Can early improvement be used to predict later response to antipsychotics in schizophrenia?

The increased risk of mood and anxiety problems found in people taking varenicline with pre-existing mental health conditions, needs to be investigated further.

Tracey Roberts summarises a recent diagnostic test review, which suggests that early improvement can act as a predictor of later response to antipsychotics in schizophrenia.

[read the full story...]

Psychotherapies for depression and anxiety in dementia

The study highlighted a lack of evidence about what CMHT services work for older people.

Clarissa Giebel summarises a recent systematic review that investigates the effectiveness of various psychotherapies (CBT, interpersonal therapy, counselling) for depression and anxiety in people with dementia or mild cognitive impairment.

[read the full story...]

Suicide prevention at suicide hotspots

16489244078_61398f287b_b

David Steele talks us through a systematic review and meta-analysis, which found that commonly used interventions are effective at preventing completed suicides at suicide hotspots.

[read the full story...]

Telemedicine psychotherapy for older veterans with depression

Veteran

Lisa Burscheidt appraises an RCT of telemedicine psychotherapy for depression in older veterans, which establishes non-inferiority of telemedicine delivery versus same-room delivery of behavioural activation.

[read the full story...]

Antidepressant meta-analyses: big business and bias

12228686746_ae22885711_b

Alex Langford reflects on the findings of a recent study that looks at 185 meta-analyses of antidepressants. It finds that industry involvement in research can lead to biased studies that under-report negative aspects of antidepressants for depression.

[read the full story...]

A fish a day keeps depression away?

shutterstock_127801319

Mark Horowitz fires up the barbecue and slices some lemons as he summarises a recent meta-analysis which concludes that higher fish consumption was found to be associated with a reduced risk of depression.

[read the full story...]

Rivastigmine for Alzheimer’s: is a small cognitive ‘improvement’ worth the risk of feeling physically unwell?

This trial suggests that antipsychotic use can be effectively reduced in nursing homes by using a review protocol.

Rosalyn Nelson presents the latest Cochrane systematic review of Rivastigmine for Alzheimer’s disease, which brings together the results of 7 industry sponsored or funded trials, and concludes that Rivastigmine may be of benefit to people with Alzheimer’s disease.

[read the full story...]

No proof that 85% of mental health apps accredited by the NHS actually work

shutterstock_137348504

Health Economist Simon Leigh argues that the unregulated world of health apps brings cause for concern as well as celebration. Fear not though, he has some suggestions for what to look out for when downloading apps, which may help whilst you’re waiting for the regulators and accreditors to get their act together.

[read the full story...]